Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations
- 21 April 2015
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 40 (11) , 2639-2647
Abstract
The endocannabinoid system has been widely involved in the pathophysiology of sensorimotor gating deficits. The present study is aimed to evaluate the pharmacological modulation of the sensorimotor gating impairment induced by cannabinoid CB1 receptor (CB1r) deletion. For this purpose, the prepulse inhibition (PPI) paradigm was used to evaluate the effect of two antipsychotics drugs (risperidone and haloperidol) and a psychostimulant (methylphenidate) on the pre-attentional deficit presented by CB1KO mice. Furthermore, the effects of the CB1r antagonist AM251 on PPI were evaluated in WT mice. Real time PCR and immunohistochemical studies were carried out to analyze dopamine transporter (DAT) and alpha-2C adrenergic receptor (ADRA2C) gene expressions and the distribution of parvalbumin (PV-ir) and cholecystokinin-8 (CCK-ir) immunoreactive cortical neurons, respectively. Neither risperidone nor haloperidol significantly modified the PPI of WT and CB1KO mice whereas methylphenidate improved the pre-attentional deficit of CB1KO mice. In addition, treatment with AM251 (3 mg/Kg; i.p.) significantly decreased the PPI of WT animals. The administration of methylphenidate increased DAT and ADRA2C gene expressions in CB1KO mice without producing any effect in WT animals. Immunohistochemical studies revealed that there were no significant changes in CCK immunolabeling between WT and CB1KO mice whereas the radial distribution of PV-ir neurons was abnormal in CB1KO mice. These data further support the important role of CB1r in sensorimotor gating regulation and the therapeutic usefulness of methylphenidate for the treatment of psychiatric disorders with associated pre-attentional deficits.Keywords
This publication has 51 references indexed in Scilit:
- Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidenceProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2014
- Reversible Disruption of Pre-Pulse Inhibition in Hypomorphic-Inducible and Reversible CB1-/- MicePLOS ONE, 2012
- Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in MiceNeuropsychopharmacology, 2011
- Driving fast-spiking cells induces gamma rhythm and controls sensory responsesNature, 2009
- Prepulse inhibition of startle in adults with ADHDJournal of Psychiatric Research, 2009
- Intact sensorimotor gating in adult attention deficit hyperactivity disorderInternational Journal of Neuropsychopharmacology, 2008
- Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterningProceedings of the National Academy of Sciences, 2008
- Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to SchizophreniaBiological Psychiatry, 2008
- Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humansJournal of Psychopharmacology, 2006
- Attention and schizophrenia: Impaired modulation of the startle reflex.Journal of Abnormal Psychology, 1993